OrbiMed Advisors
Latest statistics and disclosures from ORBIMED ADVISORS's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BSX, AMGN, Abbvie, BMY, BIIB. These five stock positions account for 22.37% of ORBIMED ADVISORS's total stock portfolio.
- Added to shares of these 10 stocks: ALXN (+$129.70M), MOH (+$109.18M), MRK (+$98.23M), ZMH (+$91.43M), MDVN (+$90.47M), Intellia Therapeutics Inc Com stock (+$56.84M), UNH (+$55.94M), SPY (+$41.89M), Eagle Pharmaceuticals (+$40.19M), EW (+$39.53M).
- Started 14 new stock positions in Alkermes, Tenet Healthcare Corporation stock, SPY, Selecta Biosciences, Eagle Pharmaceuticals, Beigene, MOH, Minerva Neurosciences, Intellia Therapeutics Inc Com stock, Pernix Therapeutics Hldgs In dbcv 4.250% 4/0. Aralez Pharmaceuticals Inc Com stock, AMED, BCR, Aeglea Biotherapeutics.
- Reduced shares in these 10 stocks: BMY (-$188.97M), CELG (-$135.06M), HCA HOLDINGS (-$126.20M), Tesaro (-$84.19M), LLY (-$83.83M), NUVA (-$74.05M), Express Scripts Holding (-$54.76M), MGLN (-$53.83M), Abbvie (-$50.93M), Allergan (-$41.16M).
- Sold out of its positions in ACAD, Anacor Pharmaceuticals In, Baxalta Incorporated, Biotie Therapies Corp. ads, CERS, Clovis Oncology, CYH, Connecture, Enanta Pharmaceuticals, ENSG. Fate Therapeutics, Gw Pharmaceuticals Plc ads, Horizon Pharma Plc convertible security, Mirati Therapeutics, Pronai Therapeutics, Tesaro, XNPT, Mylan Nv, Qiagen N.v..
- As of June 30, 2016, ORBIMED ADVISORS has $9.58B in assets under management (AUM). Assets under management grew from a total value of $9.50B to $9.58B.
- Independent of market fluctuations, ORBIMED ADVISORS was a net seller by $207.78M worth of stocks in the most recent quarter.
ORBIMED ADVISORS portfolio companies for June 2016 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Price | Last Trade |
|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | 5.64 | 23.13M +2.00% | 23.37 | 16.49 |
| Amgen (AMGN) | 4.82 | 3.03M +5.00% | 152.15 | 153.92 |
| Abbvie | 4.25 | 6.57M -11.00% | 61.91 | 0.00 |
| Bristol Myers Squibb (BMY) | 3.88 | 5.06M -33.00% | 73.55 | 66.08 |
| Biogen Idec (BIIB) | 3.79 | 1.50M | 241.82 | 415.20 |
| Alexion Pharmaceuticals (ALXN) | 3.63 | 2.98M +59.00% | 116.76 | 179.76 |
| Allergan | 3.60 | 1.49M -10.00% | 231.09 | 0.00 |
| HCA HOLDINGS | 3.29 | 4.10M -28.00% | 77.01 | 0.00 |
| Gilead Sciences (GILD) | 2.68 | 3.07M | 83.42 | 99.53 |
| Celgene Corporation (CELG) | 2.47 | 2.40M -36.00% | 98.63 | 118.26 |
| WellCare Health Plans (WCG) | 2.15 | 1.92M | 107.28 | 88.95 |
| Thermo Fisher Scientific (TMO) | 2.12 | 1.38M -4.00% | 147.76 | 127.98 |
| Intuitive Surgical (ISRG) | 2.06 | 297800 +7.00% | 661.41 | 489.66 |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.97 | 2.19M +17.00% | 86.02 | 123.26 |
| Incyte Corporation (INCY) | 1.94 | 2.32M -15.00% | 79.98 | 88.43 |
| Regeneron Pharmaceuticals (REGN) | 1.86 | 509900 -4.00% | 349.23 | 427.05 |
| UnitedHealth (UNH) | 1.78 | 1.21M +48.00% | 141.20 | 113.33 |
| Impax Laboratories (IPXL) | 1.77 | 5.89M -13.00% | 28.82 | 42.51 |
| Intercept Pharmaceuticals In | 1.67 | 1.12M | 142.68 | 0.00 |
| Agilent Technologies Inc C ommon | 1.65 | 3.57M +2.00% | 44.36 | 0.00 |
| Pfizer (PFE) | 1.56 | 4.24M +2.00% | 35.21 | 33.78 |
| Teva Pharmaceutical Industries (TEVA) | 1.45 | 2.76M +2.00% | 50.23 | 57.77 |
| Relypsa | 1.43 | 7.40M | 18.50 | 0.00 |
| Ironwood Pharmaceuticals (IRWD) | 1.36 | 9.95M -13.00% | 13.07 | 15.36 |
| Express Scripts Holding | 1.34 | 1.70M -29.00% | 75.80 | 0.00 |
| Medivation (MDVN) | 1.26 | 2.00M +299.00% | 60.30 | 127.95 |
| Wright Medical Group Nv | 1.26 | 6.95M -16.00% | 17.37 | 0.00 |
| Illumina (ILMN) | 1.24 | 846200 -5.00% | 140.38 | 191.44 |
| BioMarin Pharmaceutical (BMRN) | 1.23 | 1.52M +48.00% | 77.80 | 113.42 |
| Eli Lilly & Co. (LLY) | 1.21 | 1.48M -41.00% | 78.75 | 68.81 |
| Cooper Companies (COO) | 1.21 | 676300 -15.00% | 171.57 | 182.47 |
| Merck & Co (MRK) | 1.15 | 1.92M +810.00% | 57.61 | 56.20 |
| Molina Healthcare (MOH) | 1.14 | 2.19M NEW | 49.90 | 61.05 |
| Ophthotech | 1.14 | 2.15M +2.00% | 51.03 | 0.00 |
| Zimmer Holdings (ZMH) | 1.08 | 862500 +737.00% | 120.38 | 116.78 |
| Johnson & Johnson (JNJ) | 0.98 | 777600 +46.00% | 121.30 | 98.55 |
| Achillion Pharmaceuticals (ACHN) | 0.95 | 11.68M | 7.80 | 11.17 |
| Puma Biotechnology Inc Common Stock | 0.92 | 2.96M +7.00% | 29.79 | 0.00 |
| Allergan Plc pfd conv ser a | 0.91 | 104200 | 833.58 | 0.00 |
| Glaukos | 0.88 | 2.90M | 29.16 | 0.00 |
| Neurocrine Biosciences (NBIX) | 0.86 | 1.82M -31.00% | 45.45 | 40.28 |
| Mallinckrodt Pub | 0.83 | 1.31M | 60.78 | 0.00 |
| Corvus Pharmaceuticals | 0.80 | 5.38M +2.00% | 14.26 | 0.00 |
| Shire (SHPGY) | 0.76 | 394009 +31.00% | 184.08 | 0.00 |
| Magellan Health Services (MGLN) | 0.75 | 1.09M -42.00% | 65.77 | 65.27 |
| Humana (HUM) | 0.64 | 339700 | 179.88 | 160.10 |
| Insys Therapeutics | 0.63 | 4.69M +2.00% | 12.94 | 0.00 |
| Medtronic | 0.60 | 666299 | 86.77 | 0.00 |
| Intellia Therapeutics Inc Com stock | 0.59 | 2.66M NEW | 21.35 | 0.00 |
| Bluebird Bio | 0.54 | 1.19M +25.00% | 43.29 | 0.00 |
| Edwards Lifesciences (EW) | 0.53 | 511400 +344.00% | 99.73 | 135.16 |
| Loxo Oncology | 0.53 | 2.18M | 23.18 | 0.00 |
| Insmed | 0.45 | 4.36M +25.00% | 9.86 | 0.00 |
| SPDR S&P; 500 ETF (SPY) | 0.44 | 200000 NEW | 209.47 | 205.25 |
| CIGNA Corporation (CI) | 0.44 | 329600 | 127.99 | 120.83 |
| SPDR S&P; Biotech (XBI) | 0.42 | 745300 -24.00% | 54.08 | 226.20 |
| Eagle Pharmaceuticals | 0.42 | 1.04M NEW | 38.79 | 0.00 |
| Array BioPharma (ARRY) | 0.41 | 10.97M +2.00% | 3.56 | 7.97 |
| Dynavax Technologies | 0.37 | 2.40M +21.00% | 14.58 | 0.00 |
| Intra Cellular Therapies | 0.36 | 885400 +201.00% | 38.82 | 0.00 |
| Dimension Therapeutics | 0.34 | 5.40M | 6.00 | 0.00 |
| Viewray | 0.34 | 7.99M | 4.09 | 0.00 |
| Otonomy | 0.31 | 1.85M | 15.88 | 0.00 |
| Ascendis Pharma A S | 0.30 | 2.19M +885.00% | 13.27 | 0.00 |
| Lion Biotechnologies | 0.29 | 3.38M +230.00% | 8.10 | 0.00 |
| Stryker Corporation (SYK) | 0.27 | 212000 | 119.83 | 90.61 |
| EXACT Sciences Corporation (EXAS) | 0.27 | 2.13M +12.00% | 12.25 | 23.58 |
| Selecta Biosciences | 0.27 | 1.84M NEW | 13.99 | 0.00 |
| Tenet Healthcare Corporation stock | 0.26 | 915300 NEW | 27.64 | 0.00 |
| SYNERGY PHARMACEUTICALS | 0.24 | 5.98M +162.00% | 3.80 | 0.00 |
| Immunomedics Inc note 4.750% 2/1 | 0.22 | 30.00M | 0.69 | 0.00 |
| ImmunoGen (IMGN) | 0.20 | 6.10M | 3.08 | 7.55 |
| Galapagos Nv-spon | 0.20 | 352700 +53.00% | 55.47 | 0.00 |
| eHealth (EHTH) | 0.19 | 1.30M | 14.02 | 9.17 |
| Newlink Genetics Corporation | 0.19 | 1.58M +93.00% | 11.26 | 0.00 |
| Cynapsus Therapeutics | 0.18 | 1.14M | 15.32 | 0.00 |
| SINOVAC BIOTECH | 0.17 | 2.67M | 5.93 | 0.00 |
| Xencor | 0.17 | 870822 -21.00% | 18.99 | 0.00 |
| D Fluidigm Corp Del | 0.16 | 1.75M | 9.03 | 0.00 |
| Natera | 0.16 | 1.28M | 12.06 | 0.00 |
| Aetna (AET) | 0.15 | 116600 +53.00% | 122.13 | 100.76 |
| NuVasive (NUVA) | 0.15 | 247100 -83.00% | 59.72 | 44.67 |
| Forward Pharma A/s | 0.15 | 798000 | 18.17 | 0.00 |
| Cardinal Health (CAH) | 0.14 | 166000 | 78.01 | 87.33 |
| iShares NASDAQ Biotechnology Index (IBB) | 0.14 | 53300 -52.00% | 257.34 | 341.41 |
| Jazz Pharmaceuticals | 0.13 | 90000 | 141.31 | 0.00 |
| Proqr Thrapeutics N V shs euro | 0.12 | 2.31M | 4.84 | 0.00 |
| Pieris Pharmaceuticals | 0.12 | 7.26M | 1.61 | 0.00 |
| Inotek Pharmaceuticals | 0.11 | 1.39M | 7.44 | 0.00 |
| Abbott Laboratories (ABT) | 0.10 | 237000 | 39.31 | 46.40 |
| Affimed Therapeutics B V | 0.10 | 3.77M -3.00% | 2.48 | 0.00 |
| Cellectis S A sponsored ads | 0.10 | 350000 | 26.59 | 0.00 |
| Nabriva Therapeutics Ag | 0.10 | 1.31M | 7.50 | 0.00 |
| Immunomedics (IMMU) | 0.09 | 3.80M | 2.32 | 3.99 |
| Portola Pharmaceuticals | 0.09 | 370900 -60.00% | 23.60 | 0.00 |
| Ultragenyx Pharmaceutical | 0.09 | 169300 +31.00% | 48.91 | 0.00 |
| Sientra | 0.09 | 1.36M | 6.58 | 0.00 |
| McKesson Corporation (MCK) | 0.08 | 43400 -43.00% | 186.66 | 221.98 |
| Alkermes | 0.08 | 172000 NEW | 43.22 | 0.00 |
| Assembly Biosciences | 0.08 | 1.40M | 5.55 | 0.00 |
| Syndax Pharmaceuticals | 0.08 | 757365 | 9.85 | 0.00 |
| Incyte Corp. note 1.250 11/1 | 0.07 | 4.25M | 1.69 | 0.00 |
| Incyte Corp note 0.375%11/1 | 0.07 | 4.25M | 1.66 | 0.00 |
| Aeglea Biotherapeutics | 0.07 | 1.36M NEW | 4.86 | 0.00 |
| C.R. Bard (BCR) | 0.06 | 23000 NEW | 235.17 | 166.60 |
| Redhill Biopharma Ltd cmn | 0.06 | 564900 | 10.87 | 0.00 |
| Fluidigm Corporation convertible cor | 0.06 | 10.00M | 0.61 | 0.00 |
| Adaptimmune Therapeutics | 0.06 | 724184 +65.00% | 8.15 | 0.00 |
| Infinity Pharmaceuticals (INFI) | 0.05 | 3.25M -12.00% | 1.33 | 15.42 |
| Valeant Pharmaceuticals Int (VRX) | 0.04 | 194900 | 20.14 | 205.82 |
| Advaxis | 0.04 | 445400 -30.00% | 8.09 | 0.00 |
| Macrogenics | 0.04 | 149400 -52.00% | 26.99 | 0.00 |
| Invitae | 0.04 | 456666 | 7.39 | 0.00 |
| Minerva Neurosciences | 0.03 | 321500 NEW | 10.21 | 0.00 |
| Seres Therapeutics | 0.03 | 86000 -48.00% | 29.05 | 0.00 |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.03 | 12.00M NEW | 0.21 | 0.00 |
| Uniqure Nv shs | 0.02 | 195400 +5.00% | 7.37 | 0.00 |
| Roka Bioscience | 0.02 | 3.22M | 0.57 | 0.00 |
| Orexigen Therapeutics Inc. 144a 2 3/4% Due 12/1/2020 Jd1 note 2.750%12/0 | 0.02 | 5.21M | 0.42 | 0.00 |
| Amedisys (AMED) | 0.01 | 20000 NEW | 50.50 | 27.88 |
| Qlt | 0.01 | 500000 | 1.42 | 0.00 |
| Amarin Corporation (AMRN) | 0.01 | 350000 | 2.16 | 1.94 |
| Pernix Therapeutics Holdings (PTX) | 0.01 | 1.07M | 0.45 | 11.80 |
| Biolinerx Ltd-spons | 0.01 | 1.04M | 0.80 | 0.00 |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.01 | 500000 | 1.11 | 0.00 |
| Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.01 | 500000 | 1.16 | 0.00 |
| Marinus Pharmaceuticals | 0.01 | 867600 -10.00% | 1.27 | 0.00 |
| Cogentix Medical | 0.01 | 990745 | 0.96 | 0.00 |
| Xtant Med Holdings | 0.01 | 475439 | 1.91 | 0.00 |
| Medigus | 0.01 | 600000 | 1.82 | 0.00 |
| Alimera Sciences (ALIM) | 0.00 | 250000 -83.00% | 1.23 | 5.03 |
| Aralez Pharmaceuticals Inc Com stock | 0.00 | 68143 NEW | 3.30 | 0.00 |
| Beigene | 0.00 | 12925 NEW | 29.79 | 0.00 |
Download CSV 
Past 13F-HR SEC Filings for ORBIMED ADVISORS
- ORBIMED ADVISORS 2016 Q1 filed May 16, 2016
- ORBIMED ADVISORS 2015 Q4 filed Feb. 16, 2016
- ORBIMED ADVISORS 2015 Q3 amended filed Nov. 18, 2015
- ORBIMED ADVISORS 2015 Q3 filed Nov. 13, 2015
- ORBIMED ADVISORS 2015 Q2 amended filed Aug. 20, 2015
- ORBIMED ADVISORS 2015 Q1 filed May 15, 2015
- ORBIMED ADVISORS 2014 Q4 filed Feb. 13, 2015
- ORBIMED ADVISORS 2014 Q3 filed Nov. 14, 2014
- ORBIMED ADVISORS 2014 Q2 filed Aug. 14, 2014
- ORBIMED ADVISORS 2014 Q1 filed May 15, 2014
- ORBIMED ADVISORS 2013 Q4 filed Feb. 14, 2014
- ORBIMED ADVISORS 2013 Q3 filed Nov. 14, 2013
- ORBIMED ADVISORS 2013 Q2 filed Aug. 14, 2013
- OrbiMed Advisors 2013 Q1 filed May 15, 2013
- OrbiMed Advisors 2012 Q4 amended filed April 17, 2013
- OrbiMed Advisors 2012 Q4 amended filed Feb. 22, 2013
- OrbiMed Advisors 2012 Q4 filed Feb. 14, 2013
- OrbiMed Advisors 2012 Q3 amended filed Dec. 13, 2012
- OrbiMed Advisors 2012 Q3 filed Nov. 14, 2012